Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 10.46  

 
 

EXCLUSIVE MANUFACTURING AGREEMENT    
    

        This Exclusive Manufacturing Agreement ("Agreement") is effective November 29, 2006 ("Effective Date"), by and between Forte Automation
Systems, Inc. ("FORTE"), an Illinois corporation, and Accuray Incorporated ("ACCURAY"), a California corporation. 

 
 

RECITALS    
    

	A.
	Each
of FORTE and ACCURAY have developed technology relating to the design, apparatus, and method for a Robocouch Manipulator (the "Manipulator" or sometimes "Unit" or, when more than
one, "Units"), the specifications for which are attached hereto as Exhibit A (the "Specifications").

	B.
	ACCURAY
desires to contract with FORTE for FORTE to be the exclusive third party (but not as to Accuray) manufacturer of the Manipulator in accordance with the Specifications.

	C.
	FORTE
desires to be the exclusive third-party manufacturer of the Manipulator in consideration for the payments and other obligations of ACCURAY contained herein.

	D.
	ACCURAY
is willing to grant certain rights to ACCURAY's patent and trademarks (ACCURAY Intellectual Property listed in Exhibit B), in connection with the Manipulator, to FORTE. 

 
 

AGREEMENT    
    

        In consideration of the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt, adequacy and sufficiency of
which are hereby acknowledged, FORTE and ACCURAY agree as follows: 

	1.
	Incorporation of Recitals.    The recitals set forth above are incorporated herein by reference.

	2.
	Purchase Order.    This Agreement will enable ACCURAY to purchase Manipulators from FORTE under the terms of this Agreement by
issuance of a written purchase order. Unless the parties otherwise agree in writing, the terms and conditions of this Agreement will control and take precedence over any other conflicting term in any
purchase order.

	3.
	Term.    The term of this Agreement shall be for a period of five (5) years beginning on the Effective Date ("Term").
The Term shall automatically renew for additional one (1) year periods, unless either party has given notice to the other not less than ninety (90) days prior to the end of the Term (or
any extended Term) that they do not desire to extend the Term. 

4.     Accuray Commitments

	4.1
	Exclusivity.    During the Term of this Agreement, ACCURAY shall utilize FORTE as the exclusive, except as to Accuray:
(a) manufacturer of the Manipulator; and (b) the manufacturer of replacement parts or repair services for the Manipulator supplied by FORTE. However, nothing in this Section 4.1
shall limit ACCURAY from manufacturing the Manipulator on its own. After the first [*] Units shipped by Forte, Accuray and Forte agree to a price reduction to cost plus (x)%,
with a price not to exceed $[*] for the six axis robotic arm and the Kuka robot controller (currently $[*]) wherein such percentage shall be negotiated
in good faith based upon the then current cost of goods, determined within 30 days of the shipment date of the [*] Unit and reviewed and adjusted on an annual basis
thereafter for the remainder of the Term. A similar cost reduction shall also apply to all other components for the Manipulator. 

[*]  Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information
subject to the confidentiality request. Omissions are designated as [*]. A complete version of this exhibit has been filed separately with the Securities and Exchange
Commission. 

1

 

	4.2
	Commitment to Order.    If ACCURAY terminates this Agreement for any reason other
than material default by FORTE, then ACCURAY shall pay FORTE, within fourteen (14) business days of such termination, 100% of the price (as defined in Section 7 below) for each
Manipulator ordered by ACCURAY, plus $[*] per Unit for each Unit not ordered by ACCURAY up to [*] Units. If ACCURAY fails to order at least
[*] Units during the initial five year contract Term of this Agreement, then ACCURAY shall pay FORTE, within fourteen (14) business calendar days of the expiration of
the initial 5 year contract Term, 100% of the price (as defined in Section 7 below) for each Manipulator ordered by ACCURAY, plus $[*] per Unit for Units not
ordered by ACCURAY for up to [*] Units. To the extent that ACCURAY timely pays FORTE for Units manufactured by ACCURAY in accordance with Section 4.3, ACCURAY shall not
be required to pay the $[*] per Unit required by this section.

	4.3
	Notwithstanding
anything contained herein to the contrary, ACCURAY and FORTE agree that ACCURAY may, during the Term hereof, manufacture Unit(s) on the following terms:

	(a)
	provided
that ACCURAY has not ordered the [*] required Units of Section 4.2 above, then for each Unit manufactured by ACCURAY, ACCURAY shall pay FORTE
$[*] within fourteen (14) business days of the first to occur of the following: (i) the date on which the Unit is shipped; or (ii) the date on which
ACCURAY enters it into ACCURAY's inventory. For each Unit ACCURAY makes a payment under this Section 4.3, then a corresponding number of Units subsequently delivered by FORTE that fulfill the
[*] Units will then have a price reduction of $[*] per Unit, such price reduction to be included on the back end of the [*]
Units.

	(b)
	ACCURAY
shall keep accurate records and books with respect to the Unit(s) it manufactures during the exclusive Term, showing in sufficient detail all facts necessary for the
determination of compliance with this paragraph. FORTE shall have the right, during the Term of this Agreement and for a period of one (1) year thereafter, but no more frequently than once each
calendar year, to have such records and books examined at FORTE's expense by an independent public accountant appointed by FORTE. No information gained by such audit may or shall be disclosed to FORTE
or any third party by any accountant at any time, other than required to verify whether ACCURAY has complied with the provisions under this paragraph.

	5.
	Forecasting.    ACCURAY will supply FORTE, on a monthly basis, a rolling twelve (12) month forecast of its projected
requirements for the Manipulator. Quantities listed in any such forecast are estimates made as an accommodation made for planning purposes and do not constitute a firm commitment by ACCURAY.

	6.
	Orders and Preferential Supply.

	(a)
	The
Manipulators are delivered to ACCURAY F.O.B. Rockford. The lead time for orders shall be at least nineteen (19) weeks from the date the order is received by FORTE. FORTE's
standard Terms, Conditions, and Warranty apply to all purchase orders for Manipulators issued after the date hereof, a copy of which is attached hereto as Exhibit C. Notwithstanding the
foregoing, the terms and conditions provided in this Agreement supersede any conflicting terms of FORTE's standard Terms, Conditions, and Warranty.

	(b)
	FORTE
agrees to meet its obligations to ACCURAY before any other contracting entity for the Manipulator by committing [*]% of all available supply to ACCURAY's
orders, provided that ACCURAY has submitted a purchase order in accordance with the terms and conditions of this Agreement. 

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

2

 
	7.
	Price and Payment Terms.    ACCURAY shall pay FORTE for each Manipulator based on the
Price List attached as Exhibit D, and on the following terms: [*] due with the purchase order; [*], net 30, upon FORTE's notice to ACCURAY of
completion of a Manipulator; and [*], net 30, from the date of shipment of the Manipulator. The price may be subject to reasonable changes based on quantity discounting, due to
inflationary changes, or due to design changes. 

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

3

 
	8.
	Product Liability Insurance.    Each party shall maintain in
full force and effect product liability insurance for the Manipulator in a form satisfactory to the other in amounts of at least $[*]. Each party shall provide the other
Certificates of Insurance upon written request. All insurance policies required under this section will be written as a standard form (or ISO equivalent) and shall contain no unusual or extraordinary
exclusions.

	9.
	Representations and Warranties.

	(a)
	Each
party represents and warrants to the other that:

	(1)
	It
has the right, power and authority to enter into this Agreement and to perform its obligations hereunder; and

	(2)
	As
of the Effective Date of this Agreement, it has not received notice of any claim that any technology related to the Manipulator infringes a patent or misappropriates a trade secret
of any third party.

	(3)
	Any
changes in the design of the Manipulator by either party shall be subject to the written approval of the other, which may not be unreasonably withheld;

	(b)
	FORTE
represents and warrants as follows:

	(1)
	FORTE
shall maintain manufacturing capability to fill orders for each Manipulator;

	(2)
	FORTE
will meet ACCURAY's quality system requirements as listed in Exhibit G, and including performance of the Manipulator Acceptance Test Procedure described in
Exhibit H, prior to shipment of the Units to ACCURAY, and upon reasonable advanced written notice, to be subject to on-site quality audits by ACCURAY personnel during the term of
this Agreement;

	(3)
	FORTE
will to be ISO 9001-2000 certified by July 1, 2007 and will maintain such certification for the duration of this Agreement;

	(4)
	Its
manufacturing processes for the Manipulator are not represented in any FORTE intellectual property rights for manufacturing the Manipulator. If it is found that FORTE's
manufacturing processes for the Manipulator do amount to intellectual property rights, FORTE grants to ACCURAY a royalty-free non-sublicensable license to use FORTE's
intellectual property rights; and

	(5)
	FORTE
provides the following product warranties:

	(i)
	the
Manipulator will be free from defects in material and workmanship, and will operate in accordance with the Specifications for a minimum of one (1) year from the date of
installation at an ACCURAY customer site;

	(ii)
	the
Manipulator, except for traditionally outsourced components, will be manufactured, processed, and assembled by FORTE;

	(iii)
	the
Manipulator will conform to the Specifications;

	(iv)
	the
Manipulator will be new, except as otherwise agreed to in writing by authorized representatives of the Parties; and

	(v)
	the
Manipulator will be free and clear of all liens, encumbrances, restrictions and other claims against title or ownership. 

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

4

 
	10.
	Non-Warranty Issues.    Support for non-warranty issues requested by ACCURAY
will be billed to ACCURAY at FORTE's service rates as of the date of the service provided, including reasonable travel-related expenses, net 30 from date of invoice.

	11.
	Indemnification

	(a)
	ACCURAY
will indemnify, defend and hold FORTE harmless, including reasonable costs and attorney's fees, from and against any claims, loss, damage, causes of action, suits, and
liabilities of every kind (including reasonable attorney's fees and expenses incurred in the defense or settlement of any claim or suit or for the payment of any judgment) for injuries to or death of
any person, and damages to and destruction of property by whomsoever owned if and only to the extent caused by ACCURAY's design or manufacture of the Manipulator, claim or charge of infringement,
contributory infringement, or inducement or infringement arising from any combination by ACCURAY of the Manipulator with any other apparatus, to a proportional level that such claim is based upon the
combination.

	(b)
	FORTE
will indemnify ACCURAY and hold ACCURAY harmless from and against any and all claims, loss, damage, causes of action, suits, and liabilities of every kind (including reasonable
attorney's fees and expenses incurred in the defense or settlement of any claim or suit or for the payment of any judgment) for injuries to or death of any person, and damages to and destruction of
property by whomsoever owned if and only to the extent caused by failure of the Manipulator manufactured by FORTE to meet the Specifications. FORTE's indemnification obligations hereunder will be
reduced to a proportional level of fault if the Manipulator, after it left the control of FORTE, was:

	(i)
	modified
(except for incorporation into the ACCURAY Products);

	(ii)
	changed;

	(iii)
	altered;

	(iv)
	misused;

	(v)
	abused;
or

	(vi)
	not
serviced or maintained properly

	12.
	LIMITATION OF LIABILITY AND DAMAGES.    NOTWITHSTANDING ANYTHING ELSE CONTAINED IN THIS AGREEMENT TO THE CONTRARY, UNDER NO
CIRCUMSTANCE WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR ANY PUNITIVE, OR EXEMPLARY DAMAGES ARISING OUT OF THE PERFORMANCE OF THIS AGREEMENT OR IN FURTHERANCE OF THE PROVISIONS OR OBJECTIVES OF
THIS AGREEMENT REGARDLESS OF WHETHER SUCH DAMAGES WERE FORESEEABLE, WHETHER BASED ON TORT, WARRANTY, CONTRACT OR ANY OTHER LEGAL THEORY.

	13.
	Intellectual Property, Technology and Patent Rights.

	(a)
	ACCURAY
has granted FORTE, on even date herewith, a license pursuant to the terms of the Patent and Trademark License Agreement (the "License
Agreement") dated November 29, 2006;

	(b)
	Except
as to ProCure Treatment Centers, Inc., or a substitute thereof in the medical device area, FORTE agrees that during the term of this Agreement, it will not enter into
discussions, develop, manufacture, or sell the Manipulator or any system which has at least 5 axes (including rotation and translation motion) for the purpose of patient positioning in the medical
field; and 

5

 

	(c)
	Notwithstanding
anything to the contrary in Section 13(e), if FORTE is approached with potential new business regarding the Manipulator, FORTE agrees to bring any such
potential new business related to the Manipulator to ACCURAY's attention. If ACCURAY secures additional orders for the Manipulator, based on FORTE's business leads, ACCURAY will increase the
exclusivity provisions with FORTE, thereby using FORTE as the supplier for such new business.

	14.
	Reporting of Safety Problems.    Each party agrees to provide the other with a written communication of all suspected safety
problems which may exist with regard to the Manipulator within twenty-four (24) hours of discovery and to assist one another in implementation of any safety changes deemed necessary
as a result thereof. The parties further agree that such changes may result in reasonable changes to the pricing.

	15.
	Production Records.    Each party will maintain production records for each Manipulator for a period of ten (10) years
from the date of delivery by FORTE of each Manipulator.

	16.
	Compliance with Laws.    Each party agrees to comply with all federal, state, local and foreign laws, rules and regulations
applicable to its performance of its obligations under this Agreement. ACCURAY agrees that it will obtain all required approvals (including ownership of the 510(k) and the CE mark for the product) and
will otherwise comply with all applicable federal, state and local laws and regulations in making, selling, leasing or otherwise distributing products containing a Manipulator, including, without
limitation: (a) the export regulations of the United States applicable to any export of goods; and (b) the regulations or requirements of the FDA and/or other similar bodies in the
United States or countries outside of the United States to which ACCURAY may export its goods.

	17.
	Change in Function or Form.    ACCURAY will promptly advise FORTE of any change in design, function or form of the
Manipulator or the products as to which the Manipulator will be integrated and will promptly provide FORTE with any risk analysis it performs or has performed. FORTE reserves the right to terminate
this Agreement upon fourteen (14) business days written notice to ACCURAY in the event FORTE deems any such changes materially adverse as to pricing or materially risk adverse.

	18.
	Title and Risk of Loss.    Title to a Manipulator will pass from FORTE to ACCURAY upon FORTE's receipt of 100% of the
purchase price for the product. Risk of loss or damage for a Manipulator will pass from FORTE to ACCURAY F.O.B. FORTE.

	19.
	Document Delivery.    FORTE will deliver to ACCURAY all documentation ("Design Package") for the Manipulator as listed in
Exhibit E, including but not limited to user and technical manuals, design documentation, service manuals, and other documentation within thirty (30) days of ACCURAY's request, in
English and in an electronically reproducible format.

	20.
	Change Control.    FORTE will not make any significant changes to design manufacturability, parts, or suppliers of
significant parts (as determined solely by ACCURAY) without the prior written approval from ACCURAY, which may not be unreasonably withheld. Such changes must also comply with ACCURAY's Engineering
Change Order ("ECO") process and must be delivered to ACCURAY within thirty (30) days of ACCURAY's approval.

	21.
	Confidentiality.

	(a)
	The
parties have executed a Mutual Confidentiality Agreement ("Confidentiality Agreement"), dated on even date herewith, a copy of
which is attached (Exhibit F) and incorporated by reference herein. The terms and conditions of the Confidentiality Agreement are binding to this Agreement. 

6

 

	(b)
	With
the exception of Section 13(b) of this Agreement, this Agreement and all information contained herein (and Exhibits attached hereto) constitutes "Confidential
Information."

	22.
	Assignment.    Neither party may assign this Agreement without the other party's prior written consent (which may not be
unreasonably withheld), except that a party may assign this Agreement, without the other party's consent, to a successor or acquirer that is not a competitor of the other party, as the case may be, in
connection with a merger or acquisition, or the sale of all or substantially all of a party's assets or the sale of that portion of a party's business to which this Agreement relates. Subject to the
foregoing, this Agreement will bind and inure to the benefit of the parties' permitted successors and assigns.

	23.
	Surviving Provisions.    Notwithstanding the expiration or early termination of this Agreement, the provisions of Sections
4.2, 4.3, 7, 8, 9, 11, 12, 14, 15, 16, 21, 22, 23, and 25 will each survive in accordance with their terms.

	24.
	Default.    A party under this Agreement shall be in default of its obligations hereunder in the event it fails to fulfill a
material obligation of this Agreement ("Material Breach") which failure continues for a period of fourteen (14) business days from the date of written notice provided by the
non-breaching party (the "Cure Period"), such notice to delineate the breach. As used herein, a Material Breach shall be deemed to include, but not be limited to, any one of the following:

	(a)
	failure
by FORTE for two (2) consecutive three (3) month periods to meet delivery dates at least ninety percent (90%) of the time (a delivery shall be deemed untimely in
the event one (1) or more Manipulators are delivered more than one (1) week early or one (1) week late);

	(b)
	failure
by FORTE to deliver goods within fourteen (14) business days of the due date for delivery of Manipulators, where FORTE has failed to provide within seven
(7) days of the failure to so deliver, a plan to cure such failure to deliver with such cure to have been completed within thirty (30) days of the original delivery date;

	(c)
	failure
by ACCURAY to pay in accordance with the terms of this Agreement or failure by ACCURAY to pay in accordance with the terms of FORTE's invoices for the fourteen
(14) Units previously ordered by ACCURAY;

	(d)
	failure
by FORTE to be ISO 9001-2000 certified by July 1, 2007 and maintain such certification for the duration of this Agreement;

	(e)
	failure
by ACCURAY to abide by the exclusivity provision of Section 4.1;

	(f)
	failure
by FORTE to meet ACCURAY's quality system requirements as listed in Exhibit G, including performance of the Acceptance Test Procedure as described in Exhibit H,
prior to shipment of the Units to ACCURAY;

	(g)
	failure
by ACCURAY to abide by the provisions of Section 4.3; and

	(h)
	In
the event of a Material Breach, in addition to all other rights and remedies available under the law to the non-breaching party, the non-breaching party may
terminate this Agreement after the Cure Period, which termination shall be effective immediately upon the date of written notice to the breaching party.

	25.
	Miscellaneous provisions.

	(a)
	All
notices required hereunder shall be in writing and shall be sent by U.S. mail (first class) or nationally-recognized courier service (e.g., Federal Express), with all postage or
delivery charges prepaid, or may be sent via facsimile, subject to confirmation via U.S. mail or nationally-recognized courier service, and shall be addressed to the parties at their addresses set
forth below or to such other address(es) as may be furnished by written notice in the 

7

 

manner
set forth herein. Notices shall be deemed to have been served when delivered or, if delivery is not performed as a result of the addressee's fault, when tendered. 

	 
	 	Notices to FORTE:
 
	 	Notices to ACCURAY:

	 	 	Toby Henderson

Forte Automation Systems, Inc.

8155 Burden Road

Machesney Park, IL 61115	 	Accuray Incorporated

Attn: Chief Operating Officer

1310 Chesapeake Terrace

Sunnyvale, CA 94089
	

 	
 	

With Copy To:	
 	

With Copy To:
	

 	
 	

Jamie S. Cassel, Esq.

Reno & Zahm LLP

2902 McFarland Road, Suite 400

Rockford, IL 61107	
 	

General Counsel

	(b)
	This
Agreement shall not be construed as creating an agency, partnership or any other form of legal association between the parties other than as expressly set forth herein. Neither
party shall have any right or authority to assume or create any obligation of any kind or to make any representation or warranty on behalf of the other party, whether express or implied, or to bind
the other party in any respect whatsoever.

	(c)
	Except
for the obligation to pay money, neither party shall be liable to the other party for any failure or delay in performance caused by any acts of God or other natural disasters
or by other reasons beyond such party's reasonable control.

	(d)
	Any
litigation relating to or concerning this Agreement shall be brought only in the federal court sitting in Chicago, Illinois, and in no other place. FORTE and ACCURAY hereby
consent to the jurisdiction of such court or courts and agree to appear in any such action upon written notice thereof.

	(e)
	If
either party commences any action or proceeding against the other party to enforce this Agreement or any of its rights hereunder, the prevailing party in such action or proceeding
shall be entitled to recover from the other party the reasonable attorneys' fees and related costs and expenses incurred by such prevailing party in connection with such action or proceeding and in
connection with enforcing any judgment or order thereby obtained.

	(f)
	No
failure or delay by either party in exercising any right, power, or remedy under this Agreement shall operate as a waiver of any such right, power, or remedy. No waiver of any
provision of this Agreement shall be effective unless in writing and signed by the party against whom such waiver is sought to be enforced.

	(g)
	No
amendment to or modification of this Agreement (or any provision hereof) is determined by a court of competent jurisdiction to be illegal, invalid or otherwise unenforceable, such
provision (or part thereof) shall be enforced to the extent possible consistent with the stated intention of the parties, or, if incapable of such enforcement, shall be deemed to be deleted from this
Agreement, while the remainder of this Agreement shall continue in full force and remain in effect according to its stated terms and conditions.

	(h)
	In
the event that any provision of this Agreement (or any portion hereof) is determined by a court of competent jurisdiction to be illegal, invalid or otherwise unenforceable, such
provision (or part thereof) shall be enforced to the extent possible consistent with the stated intention of the parties, or, if incapable of such enforcement, shall be deemed to be deleted from this
Agreement, while the remainder of this Agreement shall continue in full force and remain in effect according to its stated terms and conditions. 

8

 

	(i)
	No
provisions of this Agreement, whether express or implied, are intended or shall be construed to confer upon or give to any person or entity other than the specific parties hereto
any rights, remedies or other benefits under this Agreement.

	(j)
	All
amounts due under this Agreement are quoted and are to be paid in United States Dollars.

	(k)
	The
section headings used in this Agreement are intended primarily for reference and shall not by themselves determine the construction or interpretation of this Agreement or any
portion hereof.

	(l)
	This
Agreement including all exhibits hereto, constitutes the entire agreement and understanding of the parties with respect to the subject matter hereof, and supersedes all prior and
contemporaneous correspondence, negotiations, agreements and understandings between the parties, and any representations and warranties, both oral and written. The exhibits may be updated or new
exhibits may be added to this Agreement upon the written agreement by authorized representatives of the parties.

	(m)
	This
Agreement shall be fairly interpreted in accordance with its terms and without any strict construction in favor of or against either of the parties.

	(n)
	As
of the date of this Agreement, the parties agree that there is no Material Breach that would qualify as a default under Section 24 above. 

[Signature
Page to Follow] 

REMAINDER
OF PAGE LEFT BLANK INTENTIONALLY 

9

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written. 

	Accuray Incorporated
 
	 	Forte Automation Systems, Inc.
 

	By:	 	/s/ Chris A. Raanes
	 	By:	 	/s/ Toby Henderson

	Name:	 	Chris A. Raanes	 	Name:	 	Toby Henderson
	Title:	 	SVP, Chief Operating Officer	 	Title:	 	President
	Date:	 	11/29/06	 	Date:	 	11/29/06

10

  

 
 

Exhibit A
  Specifications    
    

[*]

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

11

 
 
 

Exhibit B
  Accuray Intellectual Property    
    

Patent  

        United States Patent Application Serial No. [*] entitled, "[*]," filed [*]. 

Trademarks  

ACCURAYTM

ROBOCOUCHTM

ACCURAY LOGO

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

12

 
 
 

Exhibit C
  FORTE Standard Terms, Conditions, and Warranty    
    

13

 
 
 

FORTE AUTOMATION SYSTEMS, INC. ("FORTE")
  Terms, Conditions & Warranty    
    

	1.
	Applicable Terms.    Any order resulting from this proposal will be subject to the written acknowledgement of Forte.

	2.
	Taxes.    Any taxes or additional costs, due to the federal, state or municipal legislation, to which the prices in this
proposal are subject, will be paid by the Purchaser.

	3.
	Duration.    The price set forth in the proposal is valid for 60 days.

	4.
	Delivery.    Forte will make every reasonable effort to meet the delivery period set forth on the proposal. Delivery period
proposed is an estimate based on conditions on the date of the proposal and is subject to review and change per Forte's acknowledgement. All reference to the delivery assumes the period to start on
the date of Forte's acknowledgement of the Purchaser's formal written order, and all deliveries are contingent upon the timely performance of the Purchaser in providing component parts/part samples,
prints, and approvals as may be requested by Forte. Delivery shall be F.O.B. Forte's plant, Rockford, Illinois. Purchaser is deemed to have agreed to extend delivery date if delay is result of
Purchaser's failure to provide in timely fashion component parts/part samples, prints, and approvals as may be requested by Forte. Credit is subject to approval.

	5.
	Delays.    Forte shall not be liable for any loss or damage for delay or non-delivery due to acts of civil or
military authority, acts of the buyer, or by reason of "Force Majeure," which shall be deemed to mean all other causes not reasonably in the control of Forte, including but not limited to acts of God,
war, strikes, labor disturbances, delays of carriers, inability to secure materials, labor or manufacturing facilities. Any delay resulting from such causes shall extent corresponding shipping dates
accordingly.

	6.
	Warranties and Remedies.    Goods are warranted, to the original purchaser for use, to be free of defects in material and
workmanship within such tolerances as may be customary in the industry for a period of one year from the date of shipment. Forte, at its option, will repair or replace, or refund the purchase price of
any machine or part which fails within the warranty period and is found upon examination by Forte to be defective in material or workmanship, or both. This warranty does not cover failures
attributable to improper use or maintenance, exceeding rated capacity, alteration, accident, normal wear of moving parts, or damages caused by shipment. Computer software, accessories, controls,
hydraulics, and other components not manufactured by Forte are excluded from this warranty. For services on such parts, refer to applicable manufacturer's warranty. Purchaser must give written notice
to Forte at the address shown below of any warranty claim within thirty days after failure, and if so instructed, return to Fore the parts to be replaced or repaired, with all transportation charges
prepaid by Purchaser. Replacement parts will be invoiced to Purchaser, with credit issued for parts covered by this warranty and freight thereon. Removal and reinstallation of replacement parts shall
be at Purchaser's expense. Support for non-warranty issues will be paid by Purchaser at Forte's service rates as of the date service is provided, including reasonable travel-related
expenses. 

THERE IS NO OTHER EXPRESS WARRANTY. ANY AND ALL IMPLIED WARRANTIES, INCLUDING MERCHANTABILITY AND FITNESS FOR PARTICULAR PURPOSE, ARE HEREBY SPECIFICALLY DISCLAIMED AND
EXCLUDED BY FORTE. INCIDENTAL AND CONSEQUENTIAL DAMAGES ARE EXPRESSLY EXCLUDED FROM THE REMEDIES AVAILABLE TO PURCHASER, AND THE REMEDIES PROVIDED IN THIS WARRANTY SHALL BE
EXCLUSIVE.

14

 
	7.
	Damages.    Forte shall not be liable under any circumstances for consequential damages arising in whole or in part from any
breach by Forte, AND ALL SUCH CONSEQUENTIAL DAMAGES ARE HEREBY SPECIFICALLY DISCLAIMED AND EXCLUDED BY FORTE.

	8.
	Security Interest.    Until paid in full for the purchase price, Forte retains a security interest in all goods delivered to
Purchaser, and the products and proceeds thereof, for the purpose of securing payment of any and all indebtedness of Purchaser to Forte arising out of the sale of the goods noted hereon, together with
all costs and expenses in connection therewith, including, but not limited to, expenses of retaking, preserving, repairing, maintaining, preparing for sale, and selling said collateral as well as
reasonable attorney's fees, court costs, and other legal expenses.

	9.
	Attorney's Fees.    Forte shall be awarded its costs and attorney's fees incurred in connection with enforcing its rights and
remedies as to and against the Purchaser.

	10.
	Patent and Copyright Infringement Indemnification.    Forte shall indemnify, defend, and hold Purchaser harmless (including
attorneys' fees) from any claim that the product delivered hereunder is infringing on any valid copyright or patent, provided that Purchaser gives Forte timely written notice of such claim. Forte
shall not be responsible for any compromise made in connection with such a claim without its consent. In the event of a final judgment which prohibits Purchaser's continued use of any product by
reason of infringement, or if at any time Forte is of the opinion that any product is likely to become the cause of action for infringement, Forte may, at its sole discretion and expense, obtain the
rights to continued use of such product, replace or modify such product so that the product is no longer infringing, or remove the product involved and refund to Purchaser the price thereof as
depreciated or amortized over a five (5) year life. In no event shall Forte's liability to Purchaser under this section exceed the amount paid by Purchaser to Forte for any allegedly infringing
product. Purchaser shall indemnify, defend, and hold Forte harmless from any loss, cost, or expense (including attorneys' fees) arising: (1) in connection with any claim that the product is
infringing on a copyright or patent because of the way the product was modified, altered, or combined with any equipment, device, or software not supplied by Forte or because the product was used in a
manner for which the same was not designed; or because the goods manufactured were done so in accordance with Purchaser's specifications (or modified in any way by Purchaser); (2) and also from
any product liability claims based on alleged defects in Purchaser's design or modification.

	11.
	Special Manufactured Goods.    Purchaser shall hold harmless and defend Forte against all loss, damage, and expense
(including attorneys' fees) arising from any patent or other property right infringement claims on goods manufactured in accordance with Purchaser's specifications and from any product liability
claims based on alleged defects in Purchaser's design.

	12.
	Trade Uses, Governing Laws.    All trade uses and customs of Forte's industry shall apply to this sale and shall constitute
part of the agreement between Forte and Purchaser to the extent not inconsistent herewith. Except as modified herein, the Illinois Uniform Commercial Code shall govern this transaction. Typographical
and clerical errors are subject to correction.

	13.
	Modification.    No additions, modifications, or changes of the foregoing terms by Purchaser in connection with any order
relating hereto shall be binding upon Forte unless specifically agreed to by Forte in writing. 

Forte Automation Systems, Inc.

8155 Burden Road

Machesney Park, Illinois 61115

815/633-2300

815/633-7131 FAX

15

 
 
 

Exhibit D
  Price List for the Manipulator    
    

	PART NUMBER
	 	DESCRIPTION
	 	PRICE

	6777-100	 	Robocouch Manipulator Including:

— Six Axis Robotic Arm

— Kuka Series 2000 Robot Controller Less Power Supply	 	$	[*]
	XXXX-XXX	 	Install Accuray Supplied Electrical Modules	 	$	[*]
	XXXX-XXX	 	FAB & Install Limit Brackets for Wrist Axis	 	$	[*]
	XXXX-XXX	 	Install Touch Sensors — (Components Provided by Accuray)	 	$	[*]
	6777-500	 	7th Axis Assembly	 	$	[*]
	6777-800	 	Shipping Cart	 	$	[*]

        Prices
are F.O.B. Rockford, IL and do not include sales tax or crating for international shipment. 

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

16

 
 
 

ACCURAY
  QUANTITY DISCOUNT SCHEDULE    
    

        Discounts are based on quantities shipped and paid in full between January 1, and December 31, of a given calendar year. 

        Discounted
amounts from the previous calendar year will be rebated or applied to balances due within 30 days of year-end. 

DISCOUNTS ARE AS FOLLOWS:  

	Qty.
 
	 	Percent
	 
	[*] Units	 	[*]	%
	[*] Units	 	[*]	%
	[*] Units	 	[*]	%
	[*] Units	 	[*]	%
	[*] Units	 	[*]	%

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

17

 
 
 

Exhibit E
  Design Package for Manipulator    
    

[*]

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

18

 
 
 

Exhibit F
  Mutual Confidentiality Agreement    
    

(see
attached) 

19

 
 
 

[ACCURAY LOGO]
  
    Exhibit F
  
    MUTUAL CONFIDENTIALITY AGREEMENT    
    

        This confidentiality agreement ("Agreement") is made as of November 29, 2006 ("Effective Date") by and
between Accuray Incorporated, a California corporation having a principal place of business at Sunnyvale, California ("Accuray") and  Forte Automation Systems,
 Inc., with its principal place of business at Machesney Park, Illinois ("Interested Party").
 

 
 

RECITALS    
    

	A.
	In
the course of dealings between the Accuray and Interested Party, each party may have access to or have disclosed to it information which is of a confidential nature as that term is
later defined in this Agreement.

	B.
	Accuray
and Interested Party each desire to establish and set forth their individual obligations with respect to the other's Confidential Information (as defined herein). The party
furnishing the Confidential Information shall be the "Disclosing Party" and the party receiving the Confidential Information shall be the "Receiving Party."

	C.
	Purpose.    The purpose of this Agreement to is govern the discussions and activities of Accuray and Interested Party under
the Exclusive Manufacturing Agreement effective November 29, 2006 and the Patent and Trademark Licensing Agreement effective  November 29, 2006.

 
 

AGREEMENT    
    

        In consideration of the foregoing, Accuray and Interested Party mutually agree as follows: 

	1.
	"Confidential
Information" as used in this Agreement shall mean any and all technical and non-technical information including patent, copyright, trade secret, and
proprietary information, techniques, sketches, drawings, models, inventions, know-how, processes, apparatus, equipment, algorithms, software programs, software source documents,
preclinical or clinical data, records, databases, formulations, clinical protocols, and formulae related to the current, future and proposed products and services of each of the parties, and includes,
without limitation, their respective information concerning research, experimental work, development, design details and specification, engineering, financial information, procurement requirements,
purchasing, manufacturing, customer lists and information, business forecasts, sales and merchandising, and marketing plans and information.

	2.
	All
Confidential Information disclosed by one party to another party under this Agreement shall ultimately be in writing and bear a legend "Proprietary," "Confidential" or words of
similar import. Accordingly, all Confidential Information disclosed by a party in any manner other than writing shall be preceded by an oral statement indicating that the information is proprietary or
confidential, and shall be followed by transmittal of a written summary of the information provided to the Receiving Party with identification as "Confidential Information" and sent to the Receiving
Party within thirty (30) days of disclosure. Notwithstanding the foregoing, Confidential Information shall also include information disclosed orally or in any tangible or intangible form,
whether or not identified or marked as "Confidential" or confirmed in a written summary by the Disclosing Party, if the Receiving Party knows or reasonably should know that the information relates to
and is with the scope of Confidential Information.

	3.
	Each
of the parties agrees that it will not make use of, disseminate, or in any way circulate within its own organization any Confidential Information of the other party which is
supplied to or 

20

 

obtained
by it in writing, orally or by observation, except to the extent necessary for negotiations, discussions, and consultations with personnel or authorized representatives of the other party,
and any purpose the other party to whom such information is confidential may hereafter authorize in writing. 

	4.
	Each
of the parties agrees that it shall disclose Confidential Information of the other party only to those of its officers, employees, consultants, counsel, independent contractors,
and agents (collectively "Representatives") who need to know such information in contemplation of or in furtherance of the business relationship between the parties and have been instructed not to
disclose the Confidential Information. Each of the parties certifies that its Representatives have previously agreed, either as a condition to employment or in order to obtain the Confidential
Information, to be bound by the terms and conditions substantially similar to those of this Agreement. Each of the parties shall be responsible for any violation of this Agreement by its
Representatives and shall use reasonable efforts to restrain its Representatives (including Representatives who, subsequent to the Effective Date of this Agreement, become former Representatives) from
unauthorized use or disclosure of Confidential Information.

	5.
	Each
of the parties agrees that it shall treat all Confidential Information of the other party with the same degree of care as it accords to its own Confidential Information, and each
of the parties represents that it exercises at least reasonable care to protect its own Confidential Information.

	6.
	Each
of the parties further agrees that it shall not publish, copy or disclose any Confidential Information of the other party to any third party and that it shall use best efforts to
prevent inadvertent disclosure of such Confidential Information to any third party.

	7.
	Each
party's obligations under Paragraphs 2, 3, 4, 5 and 6 with respect to any portion of the other party's Confidential Information shall terminate six (6) years from the date
of disclosure of such Confidential Information or at such earlier time when the Receiving Party seeking to avoid its obligations under such paragraphs can document that such Confidential Information:

	(a)
	was
in the public domain at the time it was communicated to the Receiving Party by the Disclosing Party;

	(b)
	entered
the public domain prior or subsequent to the time it was communicated to the Receiving Party by the Disclosing Party through no fault of the Receiving Party;

	(c)
	was
rightfully in the Receiving Party's possession in writing free of any obligation of confidence at the time it was communicated to the Receiving Party by the Disclosing Party;

	(d)
	was
rightfully communicated to the Receiving Party free of any obligation of confidence prior or subsequent to the time it was communicated to the Receiving Party by the Disclosing
Party;

	(e)
	can
be reasonably demonstrated to have been known to or hereafter developed by employees or agents of the Receiving Party independently of and without reference to any Confidential
Information communicated to the Receiving Party by the Disclosing Party;

	(f)
	is
disclosed to Receiving Party by a third party who, to the best of Receiving Party's knowledge, is lawfully in possession of the same and has to right to make such disclosure;

	(g)
	was
communicated by the Disclosing Party to an unaffiliated third party free of any obligation of confidence; or

	(h)
	must
be disclosed in response to a valid order by a court or other governmental body, must be disclosed otherwise as required by law, or must be disclosed as necessary to establish
the rights of either party under this Agreement. 

21

 

	8.
	In
the event that Receiving Party is required in response to a valid order by a court or other governmental body or is required otherwise by law to disclose any of the Confidential
Information, Receiving Party shall provide the Disclosing Party with advance written notice of any such requirement (to the extent practicable) and shall provide reasonable assistance to Disclosing
Party if Disclosing Party desires to seek a protective order or other appropriate remedy. If, in the absence of a protective order or other remedy, Receiving Party is nonetheless legally compelled to
disclose Confidential Information, Receiving Party may, without liability hereunder, disclose that portion of the Confidential Information which Receiving Party is legally required to disclose.

	9.
	All
materials (including, without limitation, documents, drawing, models, apparatus, sketches, designs and lists) furnished to one party by the other, and which are designated in
writing to be the property of such party, shall remain the property of such party. All Confidential Information and all copies thereof will be returned to the Disclosing Party promptly following its
request therefor, or, at Disclosing Party's election, destroyed (in which instance an authorized officer of Receiving Party shall certify to Disclosing Party that such destruction has been completed).
Notwithstanding the foregoing, Receiving Party shall be entitled, solely for dispute resolution purposes, to retain one copy of the Confidential Information, including any embodiments. Any such
retained copy shall continue to be governed by the terms and conditions of this Agreement notwithstanding any termination of this Agreement.

	10.
	Neither
party shall communicate any information to the other in violation of the proprietary rights of any third party.

	11.
	Neither
party shall export, re-export, or otherwise transmit, directly or indirectly, any product, sample, information, technical data, or other materials acquired from
the other pursuant to this Agreement to any country for which the U.S. Government or any agency thereof at the time of export requires an export license or other government approval without first
obtaining such license or approval. This Paragraph shall survive any termination of this Agreement.

	12.
	Since
unauthorized disclosure of Confidential Information will diminish the value to the parties of the proprietary interests that are the subject of this Agreement, if either party
breaches any of its obligations hereunder, the other shall be entitled to equitable relief to protect its interests therein, including but not limited to injunctive relief, as well as money damages.
Receiving Party shall immediately advise Disclosing Party of any discovered breach of this Agreement by Receiving Party or its Representatives and shall reasonably cooperate, at Receiving Party's
expense, with Disclosing Party in retrieving the disclosed Confidential Information and restricting any continuing breach.

	13.
	This
Agreement shall govern all communications between the parties that are made during the period from the Effective Date of this Agreement to the date on which either party receives
from the other written notice that subsequent communications shall not be so governed, provided, however, that each party's obligations under Paragraphs 2, 3, 4, 5, and 6 with respect to Confidential
Information of the other party which it has previously received shall continue until terminated pursuant to Paragraph 7 or 8.

	14.
	Neither
party may assign this Agreement without the other party's prior written consent, except that Accuray may assign this Agreement, without Interested Party's consent, to an
affiliate or to a successor or acquirer that is not a competitor of Interested Party, as the case may be, in connection with a merger or acquisition, or the sale of all or substantially all of
Accuray's assets or the sale of that portion of Accuray's business to which this Agreement relates. Subject to the foregoing, this Agreement will bind and inure to the benefit of the parties'
permitted successors and assigns.

	15.
	Neither
party acquires any intellectual property rights under this Agreement. This Agreement imposes no obligation on either party to purchase, sell, license, transfer or otherwise
dispose of any 

22

 

technology,
services, or products. This Agreement does not create any agency or partnership relationship. The Disclosing Party warrants that it has the right to make the disclosures under this
Agreement. No other warranties are made by either party under this agreement. Any information exchanged under this agreement is provided "as is." 

	16.
	This
Agreement shall be construed in accordance with the laws of the State of Illinois, without giving effect to principles of choice of law or conflict of laws. Any action brought to
enforce the provisions hereof shall be brought in the United States Federal District Court sitting in Chicago, Illinois.

	17.
	This
Agreement may not be amended except in writing and signed by all parties hereto.

	18.
	Any
notice required to be given under this Agreement shall be deemed received upon personal delivery (including delivery by commercial courier) or three (3) days after mailing
if sent by registered or certified mail, to the addresses of the parties set forth below, or to such other address as either of the parties shall have furnished to the other in writing.

	19.
	In
the event of invalidity of any provision of this Agreement, the parties agree that such invalidity shall not affect the validity of the remaining portions of this Agreement, and
further agree to substitute for the invalid provision a valid provision which most closely approximates the intent and economic effect of the invalid provisions. 

[SIGNATURE PAGE FOLLOWS]

23

 

        IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above. By signing below the individuals represent that they possess the authority to sign on
behalf of and bind the party for which they are signing. 

	Accuray Incorporated
 
	 	Forte Automation Systems, Inc.
 

	By:	 	/s/ Toby Henderson
	 	By:	 	/s/ Chris A. Raanes

	Name:	 	Toby Henderson	 	Name:	 	Chris A. Raanes
	Title:	 	President	 	Title:	 	COO
	Date:	 	11/29/06	 	Date:	 	11/29/06

24

 
 
 

Exhibit G
  ACCURAY Quality Systems Requirements    
    

	1.
	FORTE
will build to the Specifications (Exhibit A);

	2.
	FORTE
will inspect the systems to be sure they meet the Specifications and correct for any deviations;

	3.
	FORTE
will perform the Acceptance Test Procedure (Exhibit H) and correct for any failures; and

	4.
	FORTE
will not make any changes to the Specifications or Acceptance Test Procedure without prior written approval from ACCURAY. 

25

 
 
 

Exhibit H
  Manipulator Acceptance Test Procedure    
    

[*]

[*]  Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions. 

26

QuickLinks

EXCLUSIVE MANUFACTURING AGREEMENT

RECITALS

AGREEMENT

Exhibit A Specifications

Exhibit B Accuray Intellectual Property

Exhibit C FORTE Standard Terms, Conditions, and Warranty

FORTE AUTOMATION SYSTEMS, INC. ("FORTE") Terms, Conditions & Warranty

Exhibit D Price List for the Manipulator

ACCURAY QUANTITY DISCOUNT SCHEDULE

Exhibit E Design Package for Manipulator

Exhibit F Mutual Confidentiality Agreement

[ACCURAY LOGO] Exhibit F MUTUAL CONFIDENTIALITY AGREEMENT

RECITALS

AGREEMENT

Exhibit G ACCURAY Quality Systems Requirements

Exhibit H Manipulator Acceptance Test ProcedureQuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 10.48  

        CYBERKNIFE TRANSFER AGREEMENT  

        This
CyberKnife Transfer Agreement (hereinafter called "Agreement") is made effective on the 6th day of March 2006 ("Effective Date"), by and between Accuray Incorporated
(hereinafter called "Accuray"), Marubeni Corporation and Meditec Corporation (hereinafter jointly called "Meditec") (individually a "Party" and collectively the "Parties"). 

        WHEREAS
Meditec desires to sell and transfer to Chiyoda Technol Corporation (hereinafter called "Chiyoda") [*] CyberKnife Stereotactic Radiosurgery Systems
(hereinafter called the "CyberKnife Systems"), as more fully described in the attached Annex-1. The [*] CyberKnife Systems were previously sold and delivered by
Accuray to Meditec and stored in Meditec's inventory (hereinafter called the "Inventories"), and; 

        WHEREAS
Meditec agrees to pay to Accuray the previously agreed-upon commission for the sale and purchase of the Inventories upon the terms and conditions herein set forth. 

        NOW
IT IS HEREBY AGREED as follows: 

	1.
	Each Party agrees that:

	(a)
	Meditec
shall sell to Chiyoda the Inventories at lump-sum price of U.S. $[*], such sale to take place on or about March 31, 2006. The
specific terms and conditions of the sale and purchase of the Inventories shall be set forth in a separate agreement between Chiyoda and Meditec. A copy of the agreement between Chiyoda and Meditec
shall be provided to Accuray within fifteen (15) days of execution of such agreement, but no later than March 31, 2006.

	(b)
	In
accordance with the December 10, 2003 letter agreement between the parties, Meditec shall pay U.S. $[*] to Accuray as the commission for the sale of
the Inventories.

	(c)
	Meditec
acknowledges and agrees that the outstanding amount owed by Meditec to Accuray as payment for the upgrades as described in the letter agreement dated May 20, 2003 as
amended (hereinafter called the "Upgrades") shall be U.S. $[*]. The cost of such Upgrades is set forth in the attached Annex-1. Since Meditec had paid to Accuray
U.S. $[*] as an advance payment for the Upgrades, the net payment amount owed to Accuray by Meditec is U.S. $[*].

	(d)
	Meditec
shall pay to Accuray U.S. $[*] for the cost of Gold Contracts (as defined below in Section 3).

	(e)
	Therefore,
Meditec shall pay to Accuray U.S. $[*], the total of the amounts set forth in Paragraphs 1.(b), 1.(c) and 1.(d), such payment to be made to Accuray
by means of T.T. remittance no later than April 28, 2006.

	2.
	Upgrades

	(a)
	Accuray
shall provide the Upgrades to Chiyoda in accordance with the May 20, 2003 letter agreement, at no additional cost, upon the written request of Chiyoda. Upon receipt of
such written request, Accuray shall complete the Upgrade for each CyberKnife System within ninety (90) days. However, if Accuray receives a request for an Upgrade on another CyberKnife System
before the Upgrade on the previous CyberKnife System is complete, the ninety (90) day time limit will not apply to the second CyberKnife System. 

	[*]
	Confidential
treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request.
Omissions are designated as [*]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

1

 

	(b)
	Accuray's
obligation to perform the Upgrades will expire and be deemed waived if Chiyoda has not submitted a written request for the Upgrades on or before April 30, 2008 for
delivery [ex factory] on or before June 30, 2008. Independent of ever receiving a request for upgrade work from Chiyoda, the money paid to Accuray under this agreement
is non-refundable. As such Accuray shall have no obligation to refund any money if its Upgrade obligation expires pursuant to this paragraph.

	(c)
	Any
charges incurred for ocean freight from the United States to Japan for the Inventories shall be paid by Accuray.

	(d)
	Any
change or additional work for upgrades, if necessary, shall be discussed and decided solely by Accuray and Chiyoda.

	3.
	Gold Contracts

	(a)
	As
of March 31, 2006, the outstanding balance owed by Meditec to Accuray for the Gold Contracts under the letter agreement dated December 10, 2003 as amended
(hereinafter called the "Gold Contracts") shall be U.S. $[*].

	(b)
	Meditec
shall pay such amount to Accuray in accordance with Paragraph 1.(e) above.

	(c)
	Meditec
hereby agrees that Accuray may disclose the existence and contents of the Gold Contracts to current and future users.

	4.
	CyberKnife Systems J-2 and J-3

	(a)
	This
Agreement shall not become effective unless Chiyoda receives a Letter of Intent from a legitimate customer for the rental or purchase of CyberKnife System J-2 on or
before March 31, 2006. Chiyoda is to provide Accuray with confirmation of such Letter of Intent by March 31, 2006.

	(b)
	If
the CyberKnife System J-2 Letter of Intent is subsequently cancelled or otherwise terminates, or Chiyoda does not enter into a formal contract for the rental or
purchase of CyberKnife System J-2 on or before December 31, 2006, Meditec shall make a good faith effort to cause Chiyoda to pay Accuray the sum of U.S. $[*]
by March 31, 2007.

	(c)
	If
Chiyoda does not obtain a Letter of Intent from a legitimate customer for the purchase of CyberKnife System J-3 by June 30, 2007, Meditec shall make a good faith
effort to cause Chiyoda to pay Accuray the sum of U.S. $[*] by September 30, 2007.

	(d)
	Notwithstanding
the foregoing, if Chiyoda decides on or before June 30, 2007 to accept and install CyberKnife System J3 at their facility as a demonstration machine,
Section 4(c)) shall not apply, provided that Accuray receives written notice of such decision on or before June 30, 2007.

	5.
	Obligation and Commitment

	(a)
	Upon
transferring the Inventories in accordance with the terms of this Agreement, Meditec shall be free from all obligations and commitments to Accuray relating to such Inventories,
except as otherwise set forth herein.

	(b)
	Thus,
without limiting the generality of the foregoing, Accuray and Meditec hereby release, remise, resign and forever discharge the other party and any of its affiliates, agents,
attorneys, employees, officers, directors and commissioners, from any and all manner of actions, causes of action, suits, covenants, contracts and agreements, damages, judgments, claims and demands of
any nature whatsoever, in law or in equity, of every kind and description, in relation to the Inventories which are the subject of this Agreement.

	6.
	Additional Payment Obligation.    Independent of the payments outlined above, Meditec shall pay Accuray an additional U.S.
$[*] due on outstanding invoices. The details of such invoices are set forth in the attached Annex-3. The additional payment shall be received by Accuray no later
than April 28, 2006.

	7.
	Assignment.    Neither party may assign this Agreement without the other party's prior written consent, except that Accuray may
assign this Agreement, without Meditec's consent, to an affiliate or to a successor or acquirer, as the case may be, in connection with a merger or acquisition, or the sale of all or substantially all
of Accuray's assets or the sale of that portion of Accuray's business to which this Agreement relates. Subject to the foregoing, this Agreement will bind and inure to the benefit of the parties'
permitted successors and assigns.

	8.
	Notices.    All notices required or permitted under this Agreement will be in writing and delivered in person, by overnight
delivery service, or by registered or certified mail, postage prepaid with return receipt requested, and in each instance will be deemed given upon receipt. All communications will be sent to the
addresses set forth below or to such other address as may be specified by either party in writing to the other party in accordance with this Section. 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions.

2

 

	 
	To Accuray:
 
	 	To Marubeni:
 
	 	To Meditec:
 

	 	Accuray Incorporated	 	Marubeni Corporation	 	Meditec Corporation
	 	Attention: CFO	 	Attn: General Manager,	 	Attn: President & CEO
	 	 	 	Medical Business Unit	 	 
	 	1310 Chesapeake Terrace	 	4-2, Ohtemachi, 1-Chome	 	4-2, Ohtemachi, 1-Chome
	 	Sunnyvale, CA 94089	 	Chiyoda-Ku, Tokyo	 	Chiyoda-Ku, Tokyo
	 	U.S.A.	 	Japan	 	Japan
	 	cc to: General Counsel	 	 	 	 

	9.
	Disputes and Governing Laws

	(a)
	In
the event that a dispute arises between Accuray and Meditec with respect to the subject matter governed by this Agreement, such dispute shall be settled as follows. If either party
shall have any dispute with respect to this Agreement, that party shall provide written notification to the other party in the form of a claim identifying the issue or amount disputed including a
detailed reason for the claim. The party against whom the claim is made shall respond in writing to the claim within thirty (30) days from the date of receipt of the claim document. The party
filing the claim shall have an additional thirty (30) days after the receipt of the response to either accept the resolution offered by the other party or escalate the matter. If the dispute is
not resolved, either party may notify the other in writing of their desire to elevate the claim to the President of Accuray and the President of Meditec. Each shall negotiate in good faith and use his
or her best efforts to resolve such dispute or claim. The location, format, frequency, duration and conclusion of these elevated discussions shall be left to the discretion of the representatives
involved. If the negotiations do not lead to resolution of the underlying dispute or claim to the satisfaction of either party involved, then either party may pursue resolution by the courts as
follows.

	(b)
	All
disputes under any contract concerning the subject matter governed by this Agreement, not otherwise resolved between Accuray and Meditec shall be resolved in a court of competent
jurisdiction, in San Francisco County, State of California, and in no other place. Meditec hereby consents to the jurisdiction of such court or courts and agrees to appear in any such action upon
written notice thereof. No action, regardless of form, arising out of, or in any way connected with, this Agreement or the Inventories, may be brought by any party more than two (2) years after
the cause of action has occurred.

	10.
	Waiver.    The waiver of any breach or default of any provision of this Agreement will not constitute a waiver of any other
right hereunder or of any subsequent breach or default.

	11.
	Severability.    If any provision of this Agreement is held invalid or unenforceable by a court of competent jurisdiction,
the remaining provisions of the Agreement will remain in full force and effect, and the provision affected will be construed so as to be enforceable to the maximum extent permissible by law.

	12.
	Force Majeure.    Neither party shall be responsible for any failure or delay in its performance under this Agreement (except
for the payment of money) due to causes beyond its reasonable control, including, but not limited to, labor disputes, strike, lockout, riot, war, fire, act of God, accident, failure or breakdown of
components necessary to order completion; subcontractor, supplier or customer caused delays; inability to obtain or substantial rises in the prices of labor, materials or manufacturing facilities;
curtailment of or failure to obtain sufficient electrical or other energy, raw materials or supplies; or compliance with any law, regulation or order, whether valid or invalid. 

3

 
	13.
	Amendments.    Any amendment or modification of this Agreement must be made in writing and signed by duly authorized
representatives of each party. For Accuray, a duly authorized representative must be any of the following: CEO, CFO, COO or General Counsel.

	14.
	Entire Agreement.    This Agreement contains the entire agreement between the parties hereto with respect to the subject
matter herein, and supersedes all previous understandings, representations and warranties, agreements, written and oral, made and entered into by and among Accuray, Marubeni, and Meditec in relation
to the CyberKnife Systems and the Inventories.

	15.
	Counterparts.    This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which
together will constitute one and the same instrument. 

 
 

SIGNATURE PAGE FOLLOWS    
    

4

 

        IN
WITNESS WHEREOF, the parties have executed this Agreement on the date set forth below by their duly authorized representatives. The parties acknowledge and agree that this Agreement
does not become effective until it has been signed by all parties indicated below. 

	ACCURAY INCORPORATED
 
	 	MARUBENI CORPORATION

	

By:	
 	

/s/ CHRIS A. RAANES	
 	

By:	
 	

/s/ KOICHI SATO
	 	 	
	 	 	 	

	

Name:	
 	

Chris A. Raanes	
 	

Name:	
 	

Koichi Sato
	Title:	 	Chief Operating Officer	 	Title:	 	General Manager & Unit Director

Medical Business Unit
	

Date:	
 	

 	
 	

Date:	
 	

 
	 	 	3/9/06
	 	 	 	March 6, 2006

	ACCURAY INCORPORATED
 
	 	MEDITEC CORPORATION

	

By:	
 	

/s/ DARREN J. MILLIKEN	
 	

By:	
 	

/s/ KOICHI SATO
	 	 	
	 	 	 	

	

Name:	
 	

Darren J. Milliken	
 	

Name:	
 	

Koichi Sato
	Title:	 	General Counsel	 	Title:	 	President & Chief Executive Officer
	

Date:	
 	

 	
 	

Date:	
 	

 
	 	 	3/9/06
	 	 	 	March 6, 2006

5

 
 
 

Annex-1
  Upgrade Cost List of CyberKnife    
    

	Japan-No.
 
	 	Accuray No.
	 	Total Cost (U.S. $)

	    	 	 	 	 	 
	    	 	 	 	 	 
	[*]
	    	 	 	 	 	 
	    	 	 	 	 	 
	    	 	 	 	 	 
	 	 	 	 	

	 	 	Total	 	$	[*]
	 	 	 	 	

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions.

6

  

 
 

Annex-2
  Gold Contract    
    

	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	Payment Schedule
	 	 

	 
	 	 
	 	 
	 	Effective date
	 	 
	 	2006
	 	2007
	 	2008
	 	2009
	 	 

	J No.
 
	 	 
	 	 
	 	Balance

31-Mar

2006
	 	Unit: US$

Total

	 	Customer
	 	 
	 	Year
	 	Mth
	 	Day
	 	May
	 	Nov.
	 	Jan.
	 	Feb.
	 	Mar.
	 	May
	 	Nov.
	 	Jan.
	 	Feb.
	 	Mar.
	 	May
	 	Mar.

	1	 	Ube-Konan	 	$	[*]	 	2004	 	10	 	22	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	4	 	Osaka Univ.	 	$	[*]	 	2004	 	11	 	12	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	5	 	Kumamoto	 	$	[*]	 	2005	 	4	 	25	 	$	[*]	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	$	[*]
	6	 	Tobata	 	$	[*]	 	2004	 	10	 	29	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	7	 	Okayama	 	$	[*]	 	2004	 	10	 	22	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	8	 	Fujimoto	 	$	[*]	 	2004	 	11	 	5	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	10	 	Kyushu Univ.	 	$	[*]	 	2005	 	1	 	13	 	$	[*]	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	$	[*]
	11	 	Kyoto Soseikai	 	$	[*]	 	2004	 	10	 	22	 	$	[*]	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	12	 	Tsushima	 	$	[*]	 	2005	 	1	 	20	 	$	[*]	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	$	[*]
	13	 	Oita Oka	 	$	[*]	 	2004	 	11	 	10	 	$	[*]	 	 	 	 	$	$[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]
	14	 	Imabari	 	$	[*]	 	2004	 	11	 	30	 	$	[*]	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	15	 	Kanto	 	$	[*]	 	2005	 	2	 	23	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	$	[*]
	16	 	Yokohama	 	$	[*]	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	 	 	 	 	 	 	 	 	 	$	[*]	 	 	 	 	$	[*]	 	$	[*]
	 	 	TOTAL	 	$	[*]	 	 	 	 	 	 	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]	 	$	[*]

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

7

 
 
 

Annex-3
  Outstanding Payments Owed to Accuray    
    

	Invoice #
 
	 	Amount
	 	Invoice Date

	Marubeni—012	 	$	[*]	 	February 10, 2006
	Meditec—461	 	$	[*]	 	February 10, 2006
	Meditec—462	 	$	[*]	 	February 28, 2006
	CTC-073	 	$	[*]	 	February 1, 2006
	CTC-074	 	$	[*]	 	February 1, 2006
	CTC-075	 	$	[*]	 	February 1, 2006
	CTC-076	 	$	[*]	 	February 28, 2006
	
	 	 
	Total Amount Due:	 	$	[*]	 	 

	[*]
	Certain
information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

8

QuickLinks

SIGNATURE PAGE FOLLOWS

Annex-1 Upgrade Cost List of CyberKnife

Annex-2 Gold Contract

Annex-3 Outstanding Payments Owed to Accuray

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]